With 890,000 new cases and 450,000 deaths annually, HNSCC accounts for roughly 4.5% of cancer diagnoses and deaths worldwide.

Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

IO Biotech’s off-the-shelf cancer vaccine shows promise in melanoma with key data ahead, but funding risk limits near-term ...

The diagnosis of a suspected lung, head, and neck cancer called NUT carcinoma should include additional testing capable of detecting gene fusions that are definitive markers of the disease, according ...

Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

Older women with vulvar lichen sclerosus are more likely to develop a common type of vulvar cancer if left untreated but are likely underdiagnosed, suggesting that more counseling and regular skin ...

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Proteomic-based ...

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

Sarah Waters, 33, was diagnosed with cervical cancer in 2022 after a routine smear test and has since had a full hysterectomy - saying the experience left her "broken" ...